• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Diabetes Update: 4 New Studies


Recent research reveals how social media can help young patients avoid disease complications, how EHRs may ID patients for screening, and other findings.

What do social media, EHRs, verapamil, and eggs have to do with diabetes management? Find out in these summaries of 4 studies recently published in the diabetes and nutrition literature. 


1.Diabetes Transition Service Specification. Issued by National Health Service, England, January 2016.

2. Anderson AE, Kerr WT, Thames A, et al. Electronic health record phenotyping improves detection and screening of type 2 diabetes in the general United States population: a cross-sectional, unselected, retrospective study. J Biomed Inform. 2016;60:162-168.

3. Khodneva Y, Shalev A, Frank SJ, et al. Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study.Diabetes Res Clin Prac. 2016 Jan 15. pii: S0168-8227(16)00070-X. doi: 10.1016/j.diabres.2016.01.021. [Epub ahead of print]

4. Jones SK, Koh GY, Rowling MJ, Schalinske KL. Whole egg consumption prevents diminished serum 25-hydroxycholecalciferol concentrations in type 2 diabetic rats. J Agric Food Chem. 2016;64:120-124.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.